Thomas Van Blarcom
-
- Monoclonal and Polyclonal Antibodies Research 11
- Immunology top 10%
- Biosimilars and Bioanalytical Methods 3
- Oncology top 10%
- CAR-T cell therapy research 13
- Biotechnology top 10%
-
- Viral Infectious Diseases and Gene Expression in Insects 10
- Glycosylation and Glycoproteins Research 5
- CRISPR and Genetic Engineering 2
-
- Bacteriophages and microbial interactions 7
-
- Nanowire Synthesis and Applications 4
- Co-authors
- George GeorgiouYariv MazorBrent L. IversonRobert L. MabryJavier Chaparro‐RiggersZea MeltonArvind RajpalJaume Pons
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Thomas Van Blarcom
27 papers receiving 783 citations
Peers
Comparison fields: 5 of 61
- Radiology, Nuclear Medicine and Imaging 421
- Immunology 222
- Oncology 239
- Biotechnology 64
- Molecular Biology 503
Countries citing papers authored by Thomas Van Blarcom
This map shows the geographic impact of Thomas Van Blarcom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Van Blarcom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Van Blarcom more than expected).
Fields of papers citing papers by Thomas Van Blarcom
This network shows the impact of papers produced by Thomas Van Blarcom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Van Blarcom. The network helps show where Thomas Van Blarcom may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Van Blarcom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 31 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 57 | |
| 7 | 2021 | 96 | |
| 8 | 2021 | 38 | |
| 9 | 2019 | 3 | |
| 10 | 2018 | 8 | |
| 11 | 2016 | 19 | |
| 12 | 2014 | 83 | |
| 13 | 2014 | 50 | |
| 14 | 2011 | 70 | |
| 15 | 2010 | 33 | |
| 16 | 2010 | 20 | |
| 17 | 2009 | 14 | |
| 18 | 2008 | 39 | |
| 19 | 2008 | 8 | |
| 20 | 2007 | 25 |
About Thomas Van Blarcom
Thomas Van Blarcom is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Immunology, Molecular Biology and Ecology, having authored 27 papers that have together received 814 indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Viral Infectious Diseases and Gene Expression in Insects (10 papers), Bacteriophages and microbial interactions (7 papers), Glycosylation and Glycoproteins Research (5 papers), Nanowire Synthesis and Applications (4 papers), Biosimilars and Bioanalytical Methods (3 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (421 citations), Immunology (222 citations), Oncology (239 citations), Biotechnology (64 citations) and Molecular Biology (503 citations). Thomas Van Blarcom has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include George Georgiou, Yariv Mazor, Brent L. Iverson, Robert L. Mabry, Javier Chaparro‐Riggers, Zea Melton, Arvind Rajpal, Jaume Pons, Kevin C. Lindquist and Yasmina Abdiche. Their work appears in journals such as Blood, Journal of Molecular Biology, Nature Protocols, Clinical Cancer Research and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.